Gadofullerene inhibits the degradation of apolipoprotein B100 and boosts triglyceride transport for reversing hepatic steatosis

Hepatic steatosis is a widespread metabolic disease characterized by excessive accumulation of triglyceride (TG) in liver. So far, effective approved drugs for hepatic steatosis are still in development, and removing the unnecessary TG from the hepatocytes is an enormous challenge. Here, we explore...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Sci Adv
Glavni autori: Zhou, Chen, Zhen, Mingming, Yu, Meilan, Li, Xue, Yu, Tong, Liu, Jingchao, Jia, Wang, Liu, Shuai, Li, Lei, Li, Jie, Sun, Zihao, Zhao, Zhongpu, Wang, Xinyao, Zhang, Xiaoyan, Wang, Chunru, Bai, Chunli
Format: Artigo
Jezik:Inglês
Izdano: American Association for the Advancement of Science 2020
Teme:
Research Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7556997/
https://ncbi.nlm.nih.gov/pubmed/32917715
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abc1586
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items